Skip to content
PeptideSport
TeleCareSpot logo

Provider review

TeleCareSpot review

By Derek Olsson ·

No legal entity is named anywhere, even in its own Terms

Semaglutide is $299 a month and tirzepatide $399, flat at every dose, plus an unpublished consultation fee. The seal ID it publishes does not resolve at LegitScript, and no company name appears anywhere on the site — not even in its own Terms.

Price verified

Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

On this page

The verdict

TeleCareSpot's flat, all-doses-included pricing is a real positive. Its LegitScript certification is not: we previously called it genuinely verifiable, and on a August 2026 re-check the seal ID the site publishes does not resolve at LegitScript's CDN. And no legal entity name appears anywhere on the site — not even in its own Terms and Conditions, unusual for a HIPAA-regulated telehealth operator. Its "DNA-calibrated dosing" claim is a single unsubstantiated sentence with no methodology behind it, and the consultation fee is credited but never quantified anywhere you can check before starting.

TeleCareSpot isn't on any of our comparisons yet. The providers we compare in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see how semaglutide works for what the treatment does and does not do.

Alternatives to TeleCareSpot

Other providers we work with. Compare prices before you sign up anywhere.

Who it is for, and who it is not

A good fit if

  • You want flat pricing that doesn't rise as your dose increases
  • You want flat all-inclusive pricing more than you want a certification you can check yourself — the published LegitScript seal ID did not resolve on our August 2026 re-check
  • You want multiple formats — injectable, oral tirzepatide, and phentermine — from one platform

Look elsewhere if

  • You want to know who's legally operating the platform — no entity name appears anywhere, including the Terms and Conditions
  • You're choosing this for "DNA-calibrated dosing" specifically — it's a single unexplained sentence with no methodology disclosed
  • You live in Alaska, Mississippi, or New Jersey — all confirmed excluded
  • You want to independently verify its LegitScript certification — the seal ID the site publishes did not resolve at LegitScript's CDN when we re-checked in August 2026

What it actually costs

What they advertise

Compounded semaglutide: $299/month flat on its own site.

What you actually pay, month to month

Tirzepatide runs $399/month flat — both prices apply at every dose, with no increase.

The commitment trap

The $299 headline is the semaglutide price only — tirzepatide, offered on the same site, runs $399/month instead.

Money you will meet later

  • Consultation fee, amount not published, credited toward medication if approved

Prices come from TeleCareSpot's own website and can change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.

What is included

Compare the total cost, including fees and any minimum commitment. Here is what TeleCareSpot bundles in, and what it does not.

Clinician consult

Licensed US physician review

Bloodwork / labs

Not published

Follow-ups and dose changes

No cadence published

Human support

Not published

Injection supplies

Included in the price

Shipping

No terms published

Pharmacy, labs and oversight

The pharmacy

Not named in any source we could reach.

Oversight

No cadence published.

Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.

Where you can get it

Excludes Alaska, Mississippi, and New Jersey; available elsewhere.

The honest cons

The part they would rather you skipped

TeleCareSpot's own Terms and Conditions page never names the legal entity operating the platform — the footer copyright reads only "© 2024 – All Rights Reserved" with no company name anywhere on the site, unusual for a HIPAA-regulated telehealth operator, alongside unsubstantiated scale claims ("over 300,000 Americans trust us," "98% patient satisfaction") with no citation found anywhere.

  • No legal entity name appears anywhere on the site, including its own Terms and Conditions
  • "DNA-calibrated dosing" is a single unexplained sentence with no methodology or named lab partner
  • Consultation fee amount is never published
  • Unsubstantiated scale claims ("300,000 Americans," "98% satisfaction") appear with no citation
  • The LegitScript seal ID it publishes (45936855) does not resolve at LegitScript's CDN, re-checked August 2026

Weigh these trade-offs against the costs, care and terms above. For questions to ask before enrolling, see our vendor red-flags guide.

Similar providers

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Provider offers and terms are based on TeleCareSpot's public information. Other sources, where used, are identified in this review. Prices and terms change without notice — confirm on TeleCareSpot's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.